Abstract:Evaluating the optical properties of biological tissues is needed to achieve accurate dosimetry during photodynamic therapy (PDT). Currently, accurate assessment of the photosensitizer (PS) concentration by fluorescence measurements during PDT is typically hindered by the lack of information about tissue optical properties. In the present work, a hand-held fiber-optic probe instrument monitoring fluorescence and reflectance is used for assessing blood volume, reduced scattering coefficient, and PS concentration facilitating accurate dosimetry for PDT. System validation was carried out on tissue phantoms using nonlinear least squares support machine regression analysis. It showed a high correlation coefficient (>0.99) in the prediction of the PS concentration upon a large variety of phantom optical properties. In vivo measurements were conducted in a PDT chlorine e6 dose escalating trial involving 36 male Swiss mice with Ehrlich solid tumors in which fluences of 5, 15, and 40 J cm(-2) were delivered at two fluence rates (100 and 40 mW cm(-2)). Remarkably, quantitative measurement of fluorophore concentration was achieved in the in vivo experiment. Diffuse reflectance spectroscopy (DRS) system was also used to independently measure the physiological properties of the target tissues for result comparisons. Then, blood volume and scattering coefficient measured by the fiber-optic probe system were compared with the corresponding result measured by DRS and showed agreement. Additionally, tumor hemoglobin oxygen saturation was measured using the DRS system. Overall, the system is capable of assessing the implicit photodynamic dose to predict the PDT outcome. (C) The Authors. Published by SPIE under a Creative Commons Attribution 4.0 Unported License.

A New handheld singlet oxygen detection system (SODS) and NIR light source based phantom environment for photodynamic therapy applications

Nir Area Array Ccd-Based Singlet Oxygen Luminescence Imaging for Photodynamic Therapy

A Singlet Oxygen Monitor As an in Vivo Photodynamic Therapy Dosimeter

Two-Dimensional Singlet Oxygen Imaging with Its Near-Infrared Luminescence During Photosensitization

Photodynamic Therapy Dosimetry Using Multiexcitation Multiemission Wavelength: Toward Real-Time Prediction of Treatment Outcome

Photosensitizer-Singlet Oxygen Sensor Conjugated Silica Nanoparticles for Photodynamic Therapy and Bioimaging

Monitoring of Time-Resolved Singlet Oxygen Luminescence at 1270nm by an Optical Fiber Detection System

Quantitative Monitoring of the Level of Singlet Oxygen Using Luminescence Spectra of Phosphorescent Photosensitizer.

NIR-II Ratiometric Chemiluminescent/Fluorescent Reporters for Real-Time Monitoring and Evaluating Cancer Photodynamic Therapy Efficacy.

A Novel Theranostic Nanoprobe for in Vivo Singlet Oxygen Detection and Real-Time Dose-Effect Relationship Monitoring in Photodynamic Therapy

Ultra-high Signal-to-noise Ratio Near-Infrared Chemiluminescent Probe for in Vivo Sensing Singlet Oxygen

A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light

System for Integrated Interstitial Photodynamic Therapy and Dosimetric Monitoring

Monitoring singlet oxygen in situ with delayed chemiluminescence to deduce the effect of photodynamic therapy.

A Classic Near-Infrared Probe Indocyanine Green for Detecting Singlet Oxygen

Ratiometric singlet oxygen self-detecting and oxygen self-supplying nanosensor for real-time photodynamic therapy feedback and therapeutic effect enhancement

Proof-of-principle for Two-Stage Photodynamic Therapy: Hypoxia Triggered Release of Singlet Oxygen.

Multispectral singlet oxygen luminescent dosimetry (MSOLD) for Photofrin-mediated PDT

Microfluidic Photodynamic Therapy Based on Singlet Oxygen Fluorescence Sensing

Generation of Singlet Oxygen by Persistent Luminescent Nanoparticle-Photosensitizer Conjugates: A Proof of Principle for Photodynamic Therapy without Light

A Photodynamic System Based on Endogenous Bioluminescence for in Vitro Anticancer Studies